What is the registration number for IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT?

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT is registered under USPTO registration number 8148411.

IMP

USPTO Trademark Record

REGISTERED

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT

Q: Who owns the IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT trademark?

The IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT trademark is owned by Jazz Pharmaceuticals Research UK Limited.

Q: What class is the IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT trademark registered in?

The IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT trademark is registered in Class 041 (Education & entertainment services).

Q: What is the serial number for IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT?

The USPTO serial number for IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT is 99036968.

SN 99036968·Reg 8148411·Filed Feb 11, 2025

Owner Jazz Pharmaceuticals Research UK Limited

Education; providing of training; entertainment; sporting and cultural activities.

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT (Serial No. 99036968), Registration No. 8148411, is a registered US trademark filed on Feb 11, 2025 by Jazz Pharmaceuticals Research UK Limited. This trademark covers Class 041 (Education & entertainment services).

early section 8: February 24, 2032

Mark Intelligence

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT (Reg. #8148411) is a registered US trademark that has been protecting its owner, Jazz Pharmaceuticals Research UK Limited, since 2025. The mark covers Class 041 (Education & entertainment services). Goods and services include Education; providing of training; entertainment; sporting and cultural activities.. The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 11, 2025

SERIAL

99036968

REG#

8148411

REGISTERED

Feb 24, 2026

Owner

Applicant

Jazz Pharmaceuticals Research UK Limited

Entity

Not Provided

Address

Building 730 Kent Science Park, Kent, ME9 8AG

Country

Attorney

NameMichael T. Olsen

Law firm

Michael T. Olsen Winthrop & Weinstine, P.A.

Docket

24682

Address

225 South 6th Street, Suite 3500, Minneapolis, MN 55402, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 11, 2025

Serial Number99036968

Registration No.8148411

Registration DateFeb 24, 2026

Status DateFeb 24, 2026

Published for OppositionJan 06, 2026

Mark TypeDesign with words

Attorney Docket24682

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 041Education & entertainment services

US codes: 100, 101, 107

First use anywhere: Aug 17, 2018

First use in commerce: Aug 17, 2018

Education; providing of training; entertainment; sporting and cultural activities.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

REGISTERED-PRINCIPAL REGISTER

Feb 24, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 24, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 06, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 06, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 31, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 08, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 10, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 10, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 10, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Aug 27, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 27, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 27, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Aug 21, 2025

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

ASSIGNED TO EXAMINER

Jul 19, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 11, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 11, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Feb 11, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 11, 2025

APPLICATION FILING RECEIPT MAILED

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Jazz Pharmaceuticals Research UK Limited

Other Marks in Class 041 — Education & entertainment services

Other Marks by Michael T. Olsen

Resources

Company